![](/img/cover-not-exists.png)
Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective study
David Castro-Diaz, Pilar Miranda, Francisco Sanchez-Ballester, Isabel Lizarraga, Daniel Arumí, Javier RejasVolume:
12
Language:
english
DOI:
10.1186/1471-2490-12-19
Date:
December, 2012
File:
PDF, 334 KB
english, 2012